Equities

Clinica las Condes SA

LASCONDES:SGO

Clinica las Condes SA

Actions
Health CareHealth Care Providers
  • Price (CLP)12,200.00
  • Today's Change0.00 / 0.00%
  • Shares traded258.00
  • 1 Year change-46.61%
  • Beta0.3505
Data delayed at least 20 minutes, as of Sep 17 2024 15:19 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CLP
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments17,67434,38741,516
Total Receivables, Net128,769141,778143,643
Total Inventory2,6646412,407
Prepaid expenses------
Other current assets, total1,126363696
Total current assets150,233177,168188,262
Property, plant & equipment, net377,512379,447378,101
Goodwill, net------
Intangibles, net6,9679,8109,927
Long term investments01.7218
Note receivable - long term------
Other long term assets------
Total assets562,519584,084592,750
LIABILITIES
Accounts payable29,40146,57628,738
Accrued expenses10,1387,3977,771
Notes payable/short-term debt000
Current portion long-term debt/capital leases39,05038,64923,381
Other current liabilities, total13,33615,17733,057
Total current liabilities91,925107,79892,947
Total long term debt159,090163,078183,590
Total debt198,141201,727206,971
Deferred income tax3,0521,58746,801
Minority interest0.931.661.38
Other liabilities, total41,37640,8451,361
Total liabilities295,445313,309324,701
SHAREHOLDERS EQUITY
Common stock85,95885,95885,958
Additional paid-in capital146146146
Retained earnings (accumulated deficit)180,970184,671181,945
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity267,074270,775268,049
Total liabilities & shareholders' equity562,519584,084592,750
Total common shares outstanding8.438.438.43
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.